// App-Quantinova.ai

P683 : Higher serum golimumab concentrations are significantly associated with combined clinical-biochemical remission during maintenance therapy: results from the GO-LEVEL study

Researchers

Presenter

  • M Samaan

Principal Investigators

  • G Cunningham

  • A G Tamilarasan

  • K Rawstron

  • K Hawash

  • L Beltran

  • I Koumoutsos

  • S Ray

  • J Mawdsley

  • S Anderson

  • J Sanderson

  • Z Arkir

  • P Irving

Medical Centers

  • St Thomas' Hospital, Gastroenterology, London, UK

  • Guy's & St Thomas' Hospital, Viapath Laboratories, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • golimumab

Outcome

  • N/A

Study Design

  • Open Label

  • Prospective

  • Cross-Sectional

  • Cohort

Phase

  • IV

Study Id's

  • NCT03124121

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved